Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pfoehler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Loeffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa

Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG

Autor(en):

Zaremba, Anne; Mohr, Peter; Gutzmer, Ralf; Meier, Friedegund; Pfoehler, Claudia; Weichenthal, Michael; Terheyden, Patrick; Forschner, Andrea; Leiter, Ulrike; Ulrich, Jens; Utikal, Jochen; Welzel, Julia; Kaatz, Martin; Gebhardt, Christoffer; Herbst, Rudolf; Sindrilaru, Anca; Dippel, Edgar; Sachse, Michael; Meiss, Frank; Heinzerling, Lucie; Haferkamp, Sebastian; Weishaupt, Carsten; Loeffler, Harald; Kreft, Sophia; Griewank, Klaus; Livingstone, Elisabeth; Schadendorf, Dirk; Ugurel, Selma; Zimmer, Lisa

Tübinger Autor(en):

Forschner, Andrea Lydia
Leiter-Stöppke, Ulrike

Erschienen in:

European Journal of Cancer (2023), Bd. 188, S. 140-151

Verlagsangabe:

Oxford : Elsevier Sci Ltd

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.ejca.2023.04.008

ISSN:

0959-8049